The Association of Clinical Research Professionals (ACRP) and the Alliance for Clinical Research Excellence and Safety (ACRES) have joined forces to address critical challenges facing the clinical research enterprise globally and to improve medical product development and delivery worldwide.
The Association of Clinical Research Professionals (ACRP) and the Alliance for Clinical Research Excellence and Safety (ACRES) have joined forces to address critical challenges facing the clinical research enterprise globally and to improve medical product development and delivery worldwide.
This strategic alliance creates a practical mechanism for collaboration among ACRP's clinical research professionals and ACRES' global stakeholders in the pharmaceutical, biotechnology and medical device fields.
Under the terms of their alliance agreement, the two non-profit organizations will focus on 3 issues: the education, training and credentialing of clinical research professionals globally, an expertise of ACRP; the registration and accreditation of ACRP-affiliated sites as members of the ACRES Global Network; and tools and services to enhance safety, quality, compliance, productivity and sustainability of research sites worldwide. All projects will involve the multiple stakeholders engaged in the clinical research enterprise.
In announcing ACRP'S strategic alliance with ACRES, Gary Shangold, MD, CPI®, Chair of ACRP's Association Board of Trustees, noted that "it is difficult to imagine a more natural partnership than one between ACRP and ACRES—we share a common vision based upon a shared belief that clinical research should be done right, by professionals, wherever in the world it is done. ACRP's mission is to provide global leadership to promote integrity and excellence for the clinical research profession. ACRP believes that the ACRES Global Network will provide an opportunity for such professional sites to distinguish themselves through their commitment to quality and safety of research participants."
ACRES President and Chief Executive Officer, Greg Koski, MD, PhD, a former member of the ACRP Board agreed, emphasizing the value of a global systems approach for enhancing safety, quality and efficiency of the clinical research process. "Clinical research is the essential pathway for getting safe and effective medical products to the people of the world, to improve health, productivity and quality of life. A world-wide system for clinical research will enhance safety and drive quality, standardization, inter-operability, efficiency and excellence across the entire clinical research endeavor for the benefit of all stakeholders. Our goal is to work collaboratively with the multi-stakeholder community to build a network-system that recognizes and rewards excellence in the research process while enabling the timely development of medical products. ACRP will be a superb ally in this effort."
For more than 30 years, ACRP, a non-profit professional association, has been dedicated to promoting excellence in clinical research through the development of competency based professional development, training and certification of clinical research professionals. Today, ACRP offers the only National Commission for Certifying Agencies (NCCA) accredited professional Certification Program for members of the clinical research team, including clinical research monitors (CRAs), clinical research coordinators (CRCs) and investigators (PIs). ACRP's Code of Ethics and Professional Conduct sets a standard to which clinical research professionals aspire.
ACRES is a non-profit organization operating collaboratively in the public interest to build a global system for clinical research. At the heart of this system will be a network of accredited clinical research sites with professionally certified research teams.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.